Publications by authors named "Axel Karow"

Claim this Profile
C
Catch-up growth after switch to asciminib in a twin with chronic myeloid leukaemia.
Stephanie Sembill, Michaela Marx, Ivana Eikelberg, Michaela Höfs, Tobias Fuhrmann, Axel Karow

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA in Pediatric Mature B-Cell Non-Hodgkin Lymphoma for Genotyping and Minimal Disease Monitoring.
Jana Werner, Christine Damm-Welk, Marius Rohde, Patrick Hundsdörfer, Simon Vieth, Axel Karow

Pediatr Blood Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of patients with refractory cytopenia of childhood under observation only.
Beatrice Drexler, Stephan Schwarz-Furlan, Irith Baumann, Martina Rudelius, Peter Nöllke, Axel Karow

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations.
Yvonne Lisa Behrens, Thea Reinkens, Winfried Hofmann, Amelie Gumann, Alisa Förster, Axel Karow

Br J Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What about the heart - pediatric ALL survivors show cardiopulmonary limitations in the MinimALL Study.
Felix Huber, Isabelle Schoeffl, Nicolas Mueller, Alexander Dierl, Eva-Maria Wild, Axel Karow

Eur J Pediatr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring of imatinib in paediatric chronic myeloid leukaemia: Data from a real-world setting.
Meinolf Suttorp, Stephanie Sembill, Phyllis Lensker, Verena Hildebrand, Elke Schirmer, Axel Karow

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of BCR::ABL1 Transcript Types and Response to Therapy in Pediatric Patients with Chronic Myeloid Leukemia.
Esra Seiser, Yvonne L Behrens, Sabine Lukat, Stephanie Sembill, Axel Karow

J Mol Diagn· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations.
Frédéric Millot, Mirella Ampatzidou, Nirmalya Roy Moulik, Sanjay Tewari, Alaa Elhaddad, Axel Karow

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma.
Lea L Friker, Thomas Perwein, Andreas Waha, Evelyn Dörner, Rebecca Klein, Axel Karow

Acta Neuropathol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition.
Friedrich G Kapp, Farhad Bazgir, Nagi Mahammadzade, Mehrnaz Mehrabipour, Erik Vassella, Axel Karow

Angiogenesis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase.
Laura-Jane Kramp, Christiane Heydrich-Karsten, Stephanie Sembill, Axel Karow, Thomas Lion

Ann Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation.
Mutlu Kartal-Kaess, Axel Karow, Ulrike Bacher, Thomas Pabst, Raphael Joncourt

Pediatr Hematol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohort.
Sophie Stiehler, Stephanie Sembill, Oliver Schleicher, Michaela Marx, Manfred Rauh, Axel Karow

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia.
Yvonne Lisa Behrens, Laura Gaschler, Ronny Nienhold, Thea Reinkens, Elke Schirmer, Axel Karow

Haematologica· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
Lukas Häselbarth, Sara Gamali, Domenica Saul, Manuela Krumbholz, Romy Böttcher-Loschinski, Axel Karow

BMC Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib.
Lukas Häselbarth, Axel Karow, Kristin Mentz, Martin Böttcher, Oisin Roche-Lancaster

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.
Stephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, Michael Dworzak, Krzysztof Kalwak, Axel Karow

Leukemia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers.
Gina Hofmann, Jakob Zierk, Bettina Sobik, Zofia Wotschofsky, Stephanie Sembill, Axel Karow

Sci Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.
Oliver Schleicher, Annkathrin Horndasch, Manuela Krumbholz, Stephanie Sembill, Claudia Bremensdorfer, Axel Karow

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.
Oliver Schleicher, Annkathrin Horndasch, Manuela Krumbholz, Stephanie Sembill, Claudia Bremensdorfer, Axel Karow

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase.
Axel Karow, Gudrun Göhring, Stephanie Sembill, Friederike Lutterloh, Fina Neuhaus

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Telomere Biology in Acute Lymphoblastic Leukemia.
Axel Karow, Monika Haubitz, Elisabeth Oppliger Leibundgut, Ingrid Helsen, Nicole Preising

Int J Mol Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric chronic myeloid leukaemia presenting in de novo or secondary blast phase - a comparison of clinical and genetic characteristics.
Stephanie Sembill, Gudrun Göhring, Elke Schirmer, Friederike Lutterloh, Meinolf Suttorp, Axel Karow

Br J Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
Janna A Hol, Marjolijn C J Jongmans, Hélène Sudour-Bonnange, Gema L Ramírez-Villar, Tanzina Chowdhury, Axel Karow

Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia.
Nina F Øbro, Jacob Grinfeld, Miriam Belmonte, Melissa Irvine, Mairi S Shepherd, Axel Karow

Hemasphere· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis